Table 1.
CpG site | Position (chr:bp) | Gene | Gene name | Mean meth-β in SLE | Mean meth-β in pSS | Mean meth-β in ctrl | Δβ SLE- ctrl§ | Δβ pSS- ctrl§ | p-value EWAS SLE-ctrl‡ | p-value EWAS pSS- ctrl‡ |
---|---|---|---|---|---|---|---|---|---|---|
cg03607951 | 1:79085586 | IFI44L | Interferon induced protein 44 like | 0.34 | 0.41 | 0.59 | −0.25 | −0.18 | 3.0 × 10−141 | 9.9 × 10−67 |
cg05696877 | 1:79088769 | IFI44L | Interferon induced protein 44 like | 0.41 | 0.47 | 0.67 | −0.26 | −0.20 | 1.9 × 10−120 | 2.9 × 10−50 |
cg01028142 | 2:7004578 | CMPK2 | Cytidine/uridine monophosphate kinase 2 | 0.73 | 0.81 | 0.88 | −0.15 | −0.07 | 1.2 × 10−64 | 2.8 × 10−32 |
cg10959651 | 2:7018020 | RSAD2 | Radical S-adenosyl methionine domain containing 2 | 0.16 | 0.19 | 0.27 | −0.11 | −0.07 | 2.9 × 10−110 | 1.3 × 10−34 |
cg22930808 | 3:122281881 | PARP9 | Poly(ADP-ribose) polymerase family member | 0.43 | 0.52 | 0.71 | −0.27 | −0.19 | 1.4 × 10−105 | 2.4 × 10−55 |
cg00959259 | 3:122281975 | PARP9 | Poly(ADP-ribose) polymerase family member | 0.35 | 0.41 | 0.58 | −0.23 | −0.17 | 9.3 × 10−105 | 2.6 × 10−48 |
cg06981309 | 3:146260954 | PLSCR1 | Phospholipid scramblase 1 | 0.30 | 0.39 | 0.54 | −0.24 | −0.15 | 4.9 × 10−157 | 4.1 × 10−51 |
cg17608381 | 6:29911550 | HLA-A | Major histocompatibility complex, class I, A | 0.49 | 0.48 | 0.60 | −0.11 | −0.12 | 4.8 × 10−25 | 3.4 × 10−15 |
cg07180897 | 6:32729130 | HLA-DQB2 | Major histocompatibility complex, class II, DQ beta 2 | 0.74 | 0.73 | 0.81 | −0.07 | −0.08 | 2.7 × 10−10 | 8.9 × 10−07 |
cg10152449 | 7:2444534 | CHST12 | Carbohydrate sulfotransferase 12 | 0.27 | 0.31 | 0.39 | −0.11 | −0.08 | 3.6 × 10−102 | 9.5 × 10−28 |
cg14864167 | 8:66751182 | PDE7A | Phosphodiesterase 7A | 0.51 | 0.57 | 0.65 | −0.14 | −0.08 | 3.6 × 10−41 | 1.3 × 10−18 |
cg11317199 | 9:100850391 | TRIM14 | Tripartite motif containing 14 | 0.68 | 0.66 | 0.59 | 0.09 | 0.07 | 1.5 × 10−33 | 1.1 × 10−15 |
cg05552874 | 10:91153143 | IFIT1 | Interferon induced protein with tetratricopeptide repeats 1 | 0.46 | 0.57 | 0.71 | −0.25 | −0.14 | 2.5 × 10−128 | 2.7 × 10−56 |
cg01971407 | 11:313624 | IFITM1 | Interferon induced transmembrane protein 1 | 0.40 | 0.41 | 0.48 | −0.08 | −0.07 | 3.8 × 10−53 | 3.3 × 10−30 |
cg23570810 | 11:315102 | IFITM1 | Interferon induced transmembrane protein 1 | 0.49 | 0.55 | 0.69 | −0.20 | −0.14 | 1.6 × 10−75 | 6.1 × 10−38 |
cg03038262 | 11:315262 | IFITM1 | Interferon induced transmembrane protein 1 | 0.45 | 0.48 | 0.57 | −0.12 | −0.09 | 1.6 × 10−50 | 2.7 × 10−32 |
cg20045320 | 11:319555 | NA | 0.43 | 0.46 | 0.55 | −0.13 | −0.10 | 1.0 × 10−63 | 5.3 × 10−26 | |
cg09122035 | 11:319667 | NA | 0.36 | 0.40 | 0.49 | −0.13 | −0.09 | 3.1 × 10−72 | 1.5 × 10−20 | |
cg17990365 | 11:319718 | IFITM3 | Interferon induced transmembrane protein 3 | 0.50 | 0.53 | 0.61 | −0.11 | −0.08 | 9.5 × 10−56 | 5.9 × 10−23 |
cg08926253 | 11:614761 | IRF7 | Interferon regulatory factor 7 | 0.47 | 0.52 | 0.60 | −0.13 | −0.08 | 6.8 × 10−81 | 3.8 × 10−34 |
cg27209729 | 11:64428925 | NRXN2 | Neurexin 2 | 0.54 | 0.53 | 0.61 | −0.08 | −0.08 | 9.3 × 10−50 | 4.6 × 10−27 |
cg03172657 | 16:89163625 | ACSF3 | Acyl-CoA synthetase family member 3 | 0.53 | 0.53 | 0.45 | 0.08 | 0.07 | 4.6 × 10−34 | 3.8 × 10−13 |
cg10604476 | 19:10403908 | ICAM5 | Intercellular adhesion molecule 5 | 0.55 | 0.57 | 0.48 | 0.07 | 0.09 | 1.1 × 10−13 | 5.8 × 10−11 |
cg05825244 | 20:2730488 | EBF4 | EBF family member 4 | 0.54 | 0.57 | 0.47 | 0.07 | 0.11 | 2.3 × 10−11 | 2.4 × 10−11 |
cg22862003 | 21:42797588 | MX1 | MX dynamin like GTPase 1 | 0.43 | 0.51 | 0.70 | −0.27 | −0.19 | 2.5 × 10−126 | 7.9 × 10−63 |
cg26312951 | 21:42797847 | MX1 | MX dynamin like GTPase 1 | 0.26 | 0.29 | 0.44 | −0.18 | −0.14 | 1.3 × 10−82 | 1.3 × 10−41 |
cg21549285 | 21:42799141 | MX1 | MX dynamin like GTPase 1 | 0.41 | 0.57 | 0.83 | −0.42 | −0.26 | 3.5 × 10−139 | 6.9 × 10−59 |
cg20098015 | 22:50971140 | ODF3B | Outer dense fiber of sperm tails 3B | 0.33 | 0.39 | 0.49 | −0.15 | −0.10 | 7.1 × 10−96 | 2.1 × 10−33 |
cg05523603 | 22:50973101 | NA | 0.59 | 0.64 | 0.72 | −0.13 | −0.08 | 4.7 × 10−71 | 3.8 × 10−26 |
DMCs with methylation |Δβ| > 0.07 in both case-control EWASs are listed ordered by their chromosomal position.
Methylation Δβ refers to the difference in mean methylation β between patients with SLE, respectively, pSS and control individuals, with a negative value representing decreased methylation in the patients.
P-value for the case-control EWAS.
EWAS, epigenome-wide association study; meth-β, methylation β; NA, not annotated.